vTv Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview

vTv Therapeutics

01/11/2021 13:07

* vTv Therapeutics Inc  VTVT.OQ   VTVT.O  is expected to show a
rise in quarterly revenue when it reports  results on November 3
(estimated). 
* The High Point, North Carolina-based company is expected to
report  a 18,471.4% increase in revenue to $1.3 million from $7
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for vTv Therapeutics Inc is
for a loss of 7 cents per share. For the same quarter last year,
the company reported a loss of 3 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for vTv
Therapeutics Inc is $6.75​, about 78.8% above​ its last closing
price of $1.43. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.07       -0.07      -0.01     Beat    85.7
 Mar. 31 2021  -0.06       -0.06      -0.08     Missed  -33.3
 Dec. 31 2020  -0.04       -0.05      0.02      Beat    136.4​
 Sep. 30 2020  -0.03       -0.09      -0.03     Beat    68.4
 Jun.          -0.09​      -0.09      -0.07     Beat    26.3​
 30​ 2020​                                              
                                                        ​
 Dec. 31 2019  -0.07       -0.09      -0.13     Missed  -36.8
 Sep. 30 2019  -0.06       -0.11      -0.13     Missed  -18.2
 This summary was machine generated November 1 at 13:07 GMT.  All
figures in US dollars unless otherwise stated